Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: Correlations with pathology and outcome

Cancer Letters

Volumn 254, Issue 2, 2007, Pages 227-235

  Kempkensteffen, Carsten ^a   Hinz, Stefan ^a   Schrader, Mark ^a   Christoph, Frank ^a   Magheli, Ahmed ^b   Krause, Hans ^a   Schostak, Martin ^a   Miller, Kurt ^a   Weikert, Steffen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

mRNA; Outcome; Promoter methylation; Renal cell carcinoma; XAF1

Indexed keywords

MESSENGER RNA; X LINKED INHIBITOR OF APOPTOSIS;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; MALE; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STOMACH CANCER; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, RENAL CELL; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; METHYLATION; MIDDLE AGED; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION, GENETIC;

EID: 34547258025     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.03.006     Document Type: Article

References (26)

1. Reed J.C. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17 (1999) 2941-2953
2. Igney F.H., and Krammer P.H. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2 (2002) 277-288
3. Deveraux Q.L., and Reed J.C. IAP family proteins - suppressors of apoptosis. Genes Dev. 13 (1999) 239-252
4. LaCasse E.C., Baird S., Korneluk R.G., and MacKenzie A.E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17 (1998) 3247-3259
5. Fong W.G., Liston P., Rajcan-Separovic E., St Jean M., Craig C., and Korneluk R.G. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 70 (2000) 113-122
6. Liston P., Fong W.G., Kelly N.L., Toji S., Miyazaki T., Conte D., Tamai K., Craig C.G., McBurney M.W., and Korneluk R.G. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat. Cell Biol. 3 (2001) 128-133
7. Verhagen A.M., and Vaux D.L. Cell death regulation by the mammalian IAP antagonist Diablo/Smac. Apoptosis 7 (2002) 163-166
8. Du C., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
9. Hegde R., Srinivasula S.M., Zhang Z., Wassell R., Mukattash R., Cilenti L., DuBois G., Lazebnik Y., Zervos A.S., Fernandes-Alnemri T., and Alnemri E.S. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem. 277 (2002) 432-438
10. Leaman D.W., Chawla-Sarkar M., Vyas K., Reheman M., Tamai K., Toji S., and Borden E.C. Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis. J. Biol. Chem. 277 (2002) 28504-28511
11. Deveraux Q.L., Stennicke H.R., Salvesen G.S., and Reed J.C. Endogenous inhibitors of caspases. J. Clin. Immunol. 19 (1999) 388-398
12. Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388 (1997) 300-304
13. Xia Y., Novak R., Lewis J., Duckett C.S., and Phillips A.C. Xaf1 can cooperate with TNFalpha in the induction of apoptosis, independently of interaction with XIAP. Mol. Cell Biochem. 286 (2006) 67-76
14. Tamm I., Kornblau S.M., Segall H., Krajewski S., Welsh K., Kitada S., Scudiero D.A., Tudor G., Qui Y.H., Monks A., Andreeff M., and Reed J.C. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin. Cancer Res. 6 (2000) 1796-1803
15. Tsui K.H., Shvarts O., Smith R.B., Figlin R.A., deKernion J.B., and Belldegrun A. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J. Urol. 163 (2000) 1090-1095 quiz 1295
16. Ramp U., Krieg T., Caliskan E., Mahotka C., Ebert T., Willers R., Gabbert H.E., and Gerharz C.D. XIAP expression is an independent prognostic marker in clear-cell renal carcinomas. Hum. Pathol. 35 (2004) 1022-1028
17. Yan Y., Mahotka C., Heikaus S., Shibata T., Wethkamp N., Liebmann J., Suschek C.V., Guo Y., Gabbert H.E., Gerharz C.D., and Ramp U. Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas. Br. J. Cancer 91 (2004) 1349-1357
18. Lee M.G., Huh J.S., Chung S.K., Lee J.H., Byun D.S., Ryu B.K., Kang M.J., Chae K.S., Lee S.J., Lee C.H., Kim J.I., Chang S.G., and Chi S.G. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses. Oncogene 25 (2006) 5807-5822
19. Karge III W.H., Schaefer E.J., and Ordovas J.M. Quantification of mRNA by polymerase chain reaction (PCR) using an internal standard and a nonradioactive detection method. Methods Mol. Biol. 110 (1998) 43-61
20. Kempkensteffen C., Christoph F., Weikert S., Krause H., Kollermann J., Schostak M., Miller K., and Schrader M. Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors. J. Cancer Res. Clin. Oncol. 132 (2006) 765-770
21. Lam J.S., Breda A., Belldegrun A.S., and Figlin R.A. Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma. J. Clin. Oncol. 24 (2006) 5565-5575
22. Yoo N.J., Kim H.S., Kim S.Y., Park W.S., Park C.H., Jeon H.M., Jung E.S., Lee J.Y., and Lee S.H. Immunohistochemical analysis of Smac/DIABLO expression in human carcinomas and sarcomas. Apmis 111 (2003) 382-388
23. Mizutani Y., Nakanishi H., Yamamoto K., Li Y.N., Matsubara H., Mikami K., Okihara K., Kawauchi A., Bonavida B., and Miki T. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. J. Clin. Oncol. 23 (2005) 448-454
24. Byun D.S., Cho K., Ryu B.K., Lee M.G., Kang M.J., Kim H.R., and Chi S.G. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res. 63 (2003) 7068-7075
25. Reu F.J., Bae S.I., Cherkassky L., Leaman D.W., Lindner D., Beaulieu N., MacLeod A.R., and Borden E.C. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation. J. Clin. Oncol. 24 (2006) 3771-3779
26. Zou B., Chim C.S., Zeng H., Leung S.Y., Yang Y., Tu S.P., Lin M.C., Wang J., He H., Jiang S.H., Sun Y.W., Yu L.F., Yuen S.T., Kung H.F., and Wong B.C. Correlation between the single-site CpG and expression silencing of the XAF1 gene in human gastric and colon cancers. Gastroenterology (2006)